TABLE 3

Effect of borneol on in situ formation of oxidative metabolites of valproic acid in sandwich-cultured rat hepatocytes treated with valproic acid

At 120 hours after plating, hepatocytes were pretreated with 1 mM borneol or 0.1% dimethylsulfoxide (DMSO; vehicle) for 0.5 hour. Subsequently, hepatocytes were treated with valproic acid (VPA) (10 or 15 mM) or culture medium (vehicle) in the presence of 1 mM borneol or 0.1% DMSO for 24 hours. Culture supernatants were collected at the end of the 24-hour treatment period and subjected to gas chromatography–mass spectrometry assay for the quantification of the concentrations of oxidative metabolites of VPA. Data are expressed as mean ± S.E.M. for four rats.

MetaboliteIn Situ Concentration of VPA Metabolites (µM/0.7 × 106 cells)
10 mM VPA15 mM VPA
0.1% DMSO1 mM Borneol0.1% DMSO1 mM Borneol
4-ene-VPA0.08 ± 0.010.05 ± 0.01*0.04 ± 0.010.04 ± 0.01
4-keto-VPA0.09 ± 0.010.09 ± 0.020.13 ± 0.010.16 ± 0.02
4-OH-VPA3.4 ± 0.561.4 ± 0.45*2.2 ± 0.221.9 ± 0.21
5-OH-VPA1.6 ± 0.100.94 ± 0.05*1.7 ± 0.231.3 ± 0.19
(E)-2,4-diene-VPANone detectedNone detectedNone detectedNone detected
(E,Z)-2,3′-diene-VPA0.19 ± 0.020.19 ± 0.020.18 ± 0.010.20 ± 0.01
(E,E)-2,3′-diene-VPA1.5 ± 0.091.4 ± 0.201.6 ± 0.221.5 ± 0.14
3-ene-VPA1.3 ± 0.131.2 ± 0.161.1 ± 0.131.0 ± 0.10
(E)-2-ene-VPA1.8 ± 0.161.9 ± 0.202.2 ± 0.292.2 ± 0.23
3-OH-VPA7.1 ± 0.366.2 ± 1.511 ± 3.17.2 ± 1.1
3-keto-VPA1.4 ± 0.331.1 ± 0.352.8 ± 0.752.1 ± 0.97
  • * Significantly different from the DMSO-cotreated vehicle control group, P < 0.05.